Cancer testis antigens: A new paradigm for cancer therapy

 Abstract

Cancer immunotherapy is a promising field with limited success, also due to lack of tumor-specific targets. In our attempt of exploring novel biomarkers and immunotherapeutic targets against cancer, we have discovered a novel cancer testis antigen, SPAG9, in cancers of different histological origin and demonstrated its potential role in oncogenesis.

Full Text Options
Article
Metrics
 Share
 Full Text
 Info
Pages
1194 - 1196
doi
10.4161/onci.20686
Type
Author's View
 Metrics
 Cite This Article
 Permissions
Creative Commons License Permissions
 Reprints
Cancer testis antigens: A new paradigm for cancer therapy